In the cardioprotective aspect—adiponectin protects against atherosclerosis through mechanisms at the cellular level described in the section above, resulting in inhibition of the expression of monocyte adhesion molecules and inhibition of vascular smooth muscle cell proliferation [33,34,35]. The gene discussed is ADIPOQ; the disease is atherosclerosis.